What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)
ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?
Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit
What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
Strategic Thinking to Advance Rheumatology in the New Year
One of the first efforts this coming year will be the development of the American College of Rheumatology’s (ACR’s) 2013-2016 strategic plan
Foundation Research Explores Relationship Between RA and Cardiovascular Disease
A grant from the Rheumatology Research Foundation has set two physicians on a course to examine how high-density lipoprotein (HDL) cholesterol is different in rheumatoid arthritis patients
Welcome New ACR and ARHP Leaders
The American College of Rheumatology (ACR) welcomes the newest members of the ACR board of directors and the Association of Rheumatology Health Professionals (ARHP) executive committee
The ACR Honors Contributions to Rheumatology
The American College of Rheumatology (ACR) recognizes a group of distinguished individuals for their contributions to rheumatology research, education, and patient care
ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease
More finely tuned view of ankylosing spondylitis leads to better treatment, expert says
CORRONA Team Provides Data-Based Tool to Address Rheumatology’s Questions
The Consortium of Rheumatology Researchers of North America (CORRONA) patient registry collects a host of treatment and disease indicators for a variety of rheumatic diseases at every physician visit
Therapies Aimed at Immune Cell Progenitors May Be Key to Reducing Post Myocardial Infarction Risk
Researchers have identified hematopoietic stem and progenitor cells that are liberated from bone marrow niches by a myocardial infarction.
- « Previous Page
- 1
- …
- 87
- 88
- 89
- 90
- 91
- …
- 123
- Next Page »